Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Veruska Lia Fook Alves, Walter Moises Tobias Braga, M.D., Daniela Bertolli Zanatta, Fabricio de Carvalho, Maria de Lourdes Chauffaille, Bryan E. Strauss, Gisele Wally Braga Colleoni, MD

Blood (2013) 122 (21): 3771.

https://doi.org/10.1182/blood.V122.21.3771.3771

Published: 2013

Journal Articles

Impact of the Expression of Genes Related to T Regulatory Cells on the Survival of Patients with Multiple Myeloma

Walter Moisés Tobias Braga, M.D., Bruna Raphaeli Silva, Adriana Bruscato Bortoluzo, Djordje Atanackovic, M.D., Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4005.

https://doi.org/10.1182/blood.V120.21.4005.4005

Published: 2012

Journal Articles

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Fabricio de Carvalho, Veruska Lia, Fook Alves, Walter Moisés, Tobias Braga, M.D., Celso Vieira Xavier, Jr., Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4974.

https://doi.org/10.1182/blood.V120.21.4974.4974

Published: 2012

Journal Articles

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Walter Moises Tobias Braga, M.D., Bruna Raphaeli Silva, Fabricio de Carvalho, Veruska Lia Fook Alves, Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4985.

https://doi.org/10.1182/blood.V120.21.4985.4985

Published: 2012

Journal Articles

Frequent Expression of Cancer/Testis Antigens CT7 and LAGE-1 in Advanced Stage Multiple Myeloma: Are They Possible Targets for Immunotherapy?.

Valeria Cristina da Costa Andrade, MSc, Gisele Wally Braga Colleoni, MD, PhD, Andre L. Vettore, PhD, Roberta Spetic Felix, MSc, Manuella S.S. Almeida, MD, Fabricio Carvallho, Mihoko Yamamoto, MD, PhD, Marco Antonio Zago, MD, PhD

Blood (2006) 108 (11): 5034.

https://doi.org/10.1182/blood.V108.11.5034.5034

Published: 2006

NARROW

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Impact of the Expression of Genes Related to T Regulatory Cells on the Survival of Patients with Multiple Myeloma

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Frequent Expression of Cancer/Testis Antigens CT7 and LAGE-1 in Advanced Stage Multiple Myeloma: Are They Possible Targets for Immunotherapy?.

Email alerts

ASH Publications

American Society of Hematology

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Impact of the Expression of Genes Related to T Regulatory Cells on the Survival of Patients with Multiple Myeloma

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Frequent Expression of Cancer/Testis Antigens CT7 and LAGE-1 in Advanced Stage Multiple Myeloma: Are They Possible Targets for Immunotherapy?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only